Search bioRxiv⌕ Search

Biology subjects

Zile, A.

Publications and source records attributed to Zile, A..

2 recordsLinked to original sources

HOG pathway modulation is a determinant of echinocandin treatment failure in Candidozyma auris

Candidozyma auris is a rapidly emerging fungal pathogen whose drug-resistant profile poses a formidable challenge to antifungal treatment. Echinocandins are the recommended first-line therapy for invasive C. auris infections, but resistance to this drug class is on the rise. Here we show that, beyond resistance, C. auris can readily acquire genetically encoded echinocandin tolerance, a phenotype of slow but sustained growth and increased survival at concentrations above the minimum inhibitory concentration (MIC) that reflects incomplete maximal inhibition and a reduced Hill coefficient without an increase in MIC. Tolerance was therefore undetectable by standard clinical susceptibility testing, yet it significantly reduced treatment efficacy in an immunocompromised murine model of systemic infection. Genetic dissection revealed that tolerance arises through disruption of the high-osmolarity glycerol (HOG) mitogen-activated protein kinase (MAPK) pathway through the loss of function of Ssk1, Ssk2, Pbs2 or Hog1, or specific substitutions in Nik1. The disruption of the HOG pathway did not confer fitness or virulence defects in C. auris, and in Candida albicans and Nakaseomyces glabratus, it did not confer tolerance, suggesting a unique non-essential rewiring of this pathway in C. auris. Proteomic and cell-wall analyses linked tolerance to altered cell-wall remodelling during echinocandin exposure. Evolutionary modelling and deep sequencing of FKS1 hotspots in experimentally evolved populations showed that tolerance increases the rate at which resistance-conferring FKS1 hotspot substitutions emerge. Putative high-impact mutations in HOG pathway effectors in clinical isolates suggest that this phenotype occurs in patients, where it might reduce treatment efficacy or facilitate resistance emergence. This work therefore identifies HOG-mediated acquired tolerance as a hidden clinically relevant direct and indirect determinant of echinocandin treatment failure.

microbiology↗

Position of de novo purine biosynthesis gene disruptions shapes purine-starvation phenotypes in Saccharomyces cerevisiae

Purine starvation induces a quiescence-like and stress-resistant physiological state in Saccharomyces cerevisiae, but it remains unclear whether this response is uniform across all disruptions of the de novo adenine biosynthetic pathway. Here, we used a pathway-position series of adenine-biosynthesis deletion mutants to test how the location of the metabolic blockage shapes cellular adaptation to purine starvation, using nitrogen starvation as a reference condition. Across mutants, purine starvation induced a shared core response marked by reduced growth, repression of ribosome-biogenesis and rRNA-processing modules, and accumulation of cells in G1/G0 phase. However, the magnitude and composition of the response varied systematically with pathway position. Early-pathway mutants showed the strongest desiccation tolerance and stress-associated transcriptional remodelling, whereas late-pathway mutants showed weaker protection. The ade16{Delta}ade17{Delta} double mutant was a distinct outlier, with altered carbon-flux distribution and limited stress resilience, suggesting that late-pathway disruption produces a physiologically different starvation state. Transcriptome analysis showed partial overlap with nitrogen starvation, but also pathway-position-dependent regulation of metabolic, ribosome-related, mitochondrial, and stress-response modules. Together, these results indicate that purine starvation is not a single physiological condition, but a set of related starvation states shaped by the position of the metabolic block within the purine biosynthetic pathway.

microbiology↗